Literature DB >> 29940569

Reduced Prevalence of Severe Intraventricular Hemorrhage in Very Preterm Infants Delivered after Maternal Preeclampsia.

Eva Morsing1, Karel Maršál2, David Ley1.   

Abstract

BACKGROUND: Very preterm (VPT) delivery after severe preeclampsia (PE) has been associated with adverse perinatal outcome. It is unclear whether fetal exposure to PE per se modifies the prevalence of neonatal morbidities associated with VPT birth.
OBJECTIVES: To evaluate neonatal morbidity in VPT infants exposed to maternal PE compared to morbidity in nonexposed VPT infants.
METHODS: This retrospective study consisted of all inborn infants delivered before 30 gestational weeks admitted to a tertiary-level neonatal intensive care unit between 1998 and 2014: 195 infants exposed to maternal PE were compared to 957 infants without maternal PE (background group). Prevalence rates of neonatal morbidity, cerebral palsy (CP), and mortality at 2 years of age were obtained from patient records.
RESULTS: The PE group had a lower median (IQR) birth weight (795 [262] g) and a higher median gestational age (GA) (27 [3] weeks) at birth than the background group (890 [385] g and 26 [3] weeks, respectively; both p < 0.001). Exposure to maternal PE was associated with lower rates of severe intraventricular hemorrhage (IVH) (2 vs. 11%), retinopathy of prematurity requiring treatment (2 vs. 7%), mortality (9 vs. 15%), and CP (4 vs. 8%). Exposure to PE remained associated with a reduced prevalence of severe IVH (OR 0.17, 95% CI 0.05-0.57) after adjustment for GA, multiple birth, Apgar score, delivery mode, sex, and antenatal steroid treatment.
CONCLUSION: Fetal exposure to PE is associated with a decreased rate of severe IVH following VPT birth. Studies on underlying mechanisms may provide a basis for prevention of IVH in the VPT infant.
© 2018 S. Karger AG, Basel.

Entities:  

Keywords:  Intraventricular hemorrhage; Neonate; Preeclampsia; Very preterm birth

Mesh:

Year:  2018        PMID: 29940569     DOI: 10.1159/000489039

Source DB:  PubMed          Journal:  Neonatology        ISSN: 1661-7800            Impact factor:   4.035


  6 in total

1.  Current evidence and outcomes for retinopathy of prematurity prevention: insight into novel maternal and placental contributions.

Authors:  Lara Carroll; Leah A Owen
Journal:  Explor Med       Date:  2020-02-29

2.  Mortality and neurological outcomes in extremely and very preterm infants born to mothers with hypertensive disorders of pregnancy.

Authors:  Noriyuki Nakamura; Takafumi Ushida; Masahiro Nakatochi; Yumiko Kobayashi; Yoshinori Moriyama; Kenji Imai; Tomoko Nakano-Kobayashi; Masahiro Hayakawa; Hiroaki Kajiyama; Fumitaka Kikkawa; Tomomi Kotani
Journal:  Sci Rep       Date:  2021-01-18       Impact factor: 4.379

3.  The Serine Protease HTRA-1 Is a Biomarker for ROP and Mediates Retinal Neovascularization.

Authors:  Leah A Owen; Kinsey Shirer; Samuel A Collazo; Kathryn Szczotka; Shawna Baker; Blair Wood; Lara Carroll; Benjamin Haaland; Takeshi Iwata; Lakshmi D Katikaneni; Margaret M DeAngelis
Journal:  Front Mol Neurosci       Date:  2020-11-17       Impact factor: 5.639

4.  Mothers with hypertensive disorders of pregnancy increased risk of periventricular leukomalacia in extremely preterm or extremely low birth weight infants: A propensity score analysis.

Authors:  Zhiwen Su; Weiliang Huang; Qiong Meng; Chunhong Jia; Bijun Shi; Xi Fan; Qiliang Cui; Jingsi Chen; Fan Wu
Journal:  Front Pediatr       Date:  2022-08-23       Impact factor: 3.569

5.  Fetal sex and maternal pregnancy outcomes: a systematic review and meta-analysis.

Authors:  Zoe A Broere-Brown; Maria C Adank; Laura Benschop; Myrte Tielemans; Taulant Muka; Romy Gonçalves; Wichor M Bramer; Josje D Schoufour; Trudy Voortman; Eric A P Steegers; Oscar H Franco; Sarah Schalekamp-Timmermans
Journal:  Biol Sex Differ       Date:  2020-05-11       Impact factor: 5.027

6.  Infant outcome after active management of early-onset fetal growth restriction with absent or reversed umbilical artery blood flow.

Authors:  E Morsing; J Brodszki; A Thuring; K Maršál
Journal:  Ultrasound Obstet Gynecol       Date:  2021-06       Impact factor: 7.299

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.